Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
From - Diagnostic Testing & Emerging Technologies
Current hepatitis C virus (HCV) screening strategies may not be adequate in the face of the opioid epidemic…
From - Diagnostic Testing & Emerging Technologies
What will the laboratory of the future look like?
Attendees at G2's 36th annual Lab Institute (Oct. 24-26; Washington, D.C.) got a glimpse in the keynote…
From - Diagnostic Testing & Emerging Technologies
Labs need to take a more prominent role in the broader health care ecosystem—from being a recognized member of patient care teams to being a leading player in…
From - Diagnostic Testing & Emerging Technologies
A novel fingerstick test may improve access to Toxoplasma gondii testing for pregnant women, according to…
From - Diagnostic Testing & Emerging Technologies
Artificial intelligence- (AI-) based technology is beginning to penetrate health care. Like most other clinical decision-making, several early AI applications rely upon…